A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.

“If someone does not take proper treatment for tuberculosis, it can ultimately lead to the death to the patient,” warns ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

The bacteria that cause tuberculosis harbor some natural resistance to fluoroquinolones, but biophysicists from Johns Hopkins in Baltimore may have discovered why that is and how to make the ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that doxycycline, a commonly available and inexpensive antibiotic, can improve ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, ...

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development. This ...

The Global Tuberculosis Report 2025 states that India, despite seeing a drastic drop in incidence rates since 2010, still ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

HONG KONG, Dec 11 (Reuters) - Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average and almost 10 percent of cases are resistant to the most effective first-line ...